WC
IDXX icon

Westerkirk Capital’s Idexx Laboratories IDXX Stock Holding History

Westerkirk Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Sell
1,974
-138
-7% -$88.5K 0.12% 105
2025
Q4 		$1.43M Buy
2,112
+864
+69% +$588K 0.14% 94
2025
Q3 		$797K Sell
1,248
-113
-8% -$68.6K 0.09% 164
2025
Q2 		$730K Buy
+1,361
New +$651K 0.09% 167

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Westerkirk Capital's IDXX Position: Q1 2026 in Review

Westerkirk Capital reduced its Idexx Laboratories (IDXX) stake by 6.5% in Q1 2026, selling an estimated $88.5K and leaving 1,974 shares worth $1.11M. The position accounts for 0.12% of the portfolio, ranked #105.

Westerkirk Capital first reported a position in IDXX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.43M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Westerkirk Capital held 1,974 shares of Idexx Laboratories worth $1.11M as of Q1 2026.
  • Westerkirk Capital sold 138 Idexx Laboratories shares in Q1 2026, an estimated $88.5K.
  • Idexx Laboratories made up 0.12% of Westerkirk Capital's portfolio in Q1 2026, its #105 holding.
  • Westerkirk Capital first reported a position in Idexx Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Westerkirk Capital's Idexx Laboratories position peaked at $1.43M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Westerkirk Capital's 13F filing for Q1 2026, filed 14 May 2026.